<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00625911</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-01-AW-114-CTIL</org_study_id>
    <nct_id>NCT00625911</nct_id>
  </id_info>
  <brief_title>Ketamine Improves Post-Thoracotomy Analgesia</brief_title>
  <official_title>Ketamine Improves Post-Thoracotomy Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracotomy for lung tumor or for minimally invasive direct coronary artery bypass (MIDCAB)&#xD;
      surgery, may be associated with debilitating pain. Ketamine was shown to enhance opioid&#xD;
      antinociception and prevent opioid resistance. We hypothesize that ketamine given with&#xD;
      morphine would lower morphine consumption and narcotic related side effects after thoracotomy&#xD;
      and provide superior analgesia to morphine given alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We planned a prospective, randomomized, double blind study of 2 pain management protocols in&#xD;
      consecutive patients undergoing thoracotomy for MIDCAB or lung tumor resection over a 6 month&#xD;
      period. After patients emerged from a standardized general anesthetic and when objectively&#xD;
      awake and complaining of pain &gt;5/10 on a visual analogue pain scale, they were connected to&#xD;
      an intravenous patient controlled analgesia regimen. The regimen was assigned randomly to be&#xD;
      either morphine alone (1.5 mg per dose, lockout interval of 7 minutes) or morphine plus&#xD;
      ketamine (1.0 mg morphine plus 5 mg ketamine per dose, same lockout interval). Rescue&#xD;
      diclofenac was available to both groups. Follow-up lasted 4 hours.&#xD;
&#xD;
      We planned to monitor and compare pain scores, wakefulness scores, hemodynamic and&#xD;
      respiratory parameters as well as total morphine consumption and incidence of side effects&#xD;
      and complications. All monitoring and recording was done by blinded nurses and intensive care&#xD;
      physicians.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">March 2002</completion_date>
  <primary_completion_date type="Actual">March 2002</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic and respiratory parameters, side effects</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>morphine only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard analgesia protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>morphine ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>alterantive regimen for intravenous patient controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
    <description>intravenous patient controlled analgesia, standard protocol</description>
    <arm_group_label>morphine only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine ketamine</intervention_name>
    <description>low dose ketamine added to 2/3 standard dose of morphine</description>
    <arm_group_label>morphine ketamine</arm_group_label>
    <other_name>ketalar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consecutive patients scheduled for elective minimally invasive direct coronary artery&#xD;
             bypass (MIDCAB) or for lung resection via anterolateral thoracotomy during a 6-month&#xD;
             period (Sep 2001-March 2002)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria were:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical class â‰¥3, Emergency operations,&#xD;
&#xD;
          -  Q-wave myocardial infarct occurring during the previous 3 weeks, or poor left&#xD;
             ventricular function (e.g., ejection fraction [EF] &lt;30% by echocardiography or&#xD;
             angiography).&#xD;
&#xD;
        Other exclusion criteria were:&#xD;
&#xD;
          -  A body mass index &gt;35 kg/m2,&#xD;
&#xD;
          -  Past or current neuropathy or psychological disturbances,&#xD;
&#xD;
          -  The use of centrally active drugs,&#xD;
&#xD;
          -  Chronic liver or renal failure requiring dialysis,&#xD;
&#xD;
          -  A FEV1/FVC &lt;70%,&#xD;
&#xD;
          -  Allergy to ketamine, morphine or non steroidal anti inflammatory drugs (NSAIDs),&#xD;
&#xD;
          -  Clotting abnormalities,&#xD;
&#xD;
          -  A platelets count &lt;70000/mm3,&#xD;
&#xD;
          -  A white blood count &lt;3000&gt;14000/mm3,&#xD;
&#xD;
          -  Uncontrolled diabetes mellitus or fasting blood glucose &gt;250 g/dl,&#xD;
&#xD;
          -  Evidence of sepsis or infection up to one week prior to randomization.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avi A Weinbroum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64238</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <study_first_submitted>February 8, 2008</study_first_submitted>
  <study_first_submitted_qc>February 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2008</study_first_posted>
  <last_update_submitted>February 28, 2008</last_update_submitted>
  <last_update_submitted_qc>February 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Avi A Weinbroum, MD</name_title>
    <organization>Tel Aviv Sourasky Medical Center</organization>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>minimally invasive direct coronary artery bypass</keyword>
  <keyword>ketamine</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

